The Green Market Report hosted a virtual event on May 12, 2021, titled, “The State of Psychedelic Investing.” The webinar was hosted by GMR CEO Debra Borchardt and featured Joel Bartch – CEO of Mydecine Innovations Group, Ronan Levy – Founder and CEO of Field Trip Health, and Simeon Schnapper – Founder of JLS Fund. These industry experts talked about managing investor expectations in the psychedelic industry. They also discussed the future of psychedelics and where they see the best opportunities. This is a recording of that event.
One comment
Faeleas Raingrove
May 20, 2021 at 9:17 am
nice video, 2020 marked the beginning of the psychedelics investment story as the capital markets fully embraced the alternative drug sector